Alliance for Cancer Gene Therapy wants to vary the C-word from Cancer to Cure — building on the life-changing success of CAR-T therapies for blood cancers, the organization is now focused on the urgent got to translate this success into therapies to fight more sorts of cancer, like solid tumor cancers.
On April 29, 2021, the organization is bringing together the world’s most famous scientists and corporations who are driving the newest advances in neoplastic cell and gene therapy for solid tumors to the Alliance for Cancer Gene Therapy Summit 2021.
The Summit 2021 are going to be held online on Thursday, April 29, 2021, from 10:00 a.m. until 6:00 p.m (ET), and provides the unique opportunity to attach with leading researchers developing subsequent generation neoplastic cell and gene therapies, biotech companies who are bringing new treatments through the clinic, and investors who are funding this burgeoning pipeline of solid tumors breakthroughs. a complete of eight panels will discuss advances in solid tumor therapies with featured panels tackling the best challenges in hard-to-treat cancers like carcinoma and glioblastoma, a brain cancer.
“It’s so rare to possess the chance to listen to from the world’s top cancer researchers, biotechs, investors and patients beat an equivalent room,” noted Barbara Lavery, chief program officer for Alliance for Cancer Gene Therapy. “We’re excited to possess Alliance for Cancer Gene Therapy be the catalyst for these important conversations which will help not only other scientists performing on new cell and gene therapy approaches, but companies seeking investment to advance their clinical pipelines, and patients and their families trying to find potentially life changing therapeutic options in their fight against cancer.”
The day wraps up with a keynote presentation titled, “Does Cancer Have a Future?” with Nobel prize Laureate James P. Allison, PhD, University of Pennsylvania’s Carl H. June, MD, who may be a TIME magazine person of the year, and Pulitzer Prize winning author and oncologist Siddhartha Mukherjee, MD, author of The Emperor of All Maladies. to find out more, see the list of speakers and panels and register for the event, visit the web site Alliance for Cancer Gene Therapy Summit 2021.
Alliance for Cancer Gene Therapy was founded in 2001 and have become one among the primary and only funding agencies to embrace a progressive vision for the underfunded but exceptionally promising discipline of neoplastic cell and gene therapy. The organization quickly became a catalytic force in shaping entirely new cancer treatment models by identifying, funding, and advancing the foremost innovative and impactful translational research in cell and gene therapies. To date, Alliance for Cancer Gene Therapy has awarded $30.7 million in grants to world class cancer researchers representing the highest medical institutions within the US and Canada, advancing new approaches to leukemia, lymphoma, ovarian, prostate, sarcoma, glioblastoma, melanoma, lung and pancreatic cancers.